Group 1: Company Overview - Longlai Biopharmaceutical Co., Ltd. specializes in the production of cardiovascular drug intermediates, with over 70% of its products exported to Europe, America, and India [1] - The company has established long-term collaborations with top 20 global pharmaceutical companies, leveraging its innovation in raw materials and key intermediates [1] - Longlai Biopharmaceutical invests over 10% of its annual revenue in R&D, focusing on chronic diseases and oncology, and has over 80 domestic and international invention patents [1] Group 2: Industry Development - Jinxian County is enhancing its industrial competitiveness through technological innovation, with a focus on medical devices and advanced manufacturing [1] - The county has established a modern medical device innovation research institute in collaboration with Nanchang University, and has received approval for multiple national and provincial R&D platforms [2] - Jianglian Heavy Industry Group has been recognized in the ENR Global Top 250 International Contractors list for the eighth time, emphasizing its innovation-driven approach and high-quality products [2]